United States Antidiabetics Market Report 2017

January 2017 | 110 pages | ID: U50972ADD57EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetics

Revenue, means the sales value of Antidiabetics

This report studies sales (consumption) of Antidiabetics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novo Nordisk
• Sanofi
• Eli Lilly
• GlaxoSmithKline
• Merck
• MannKind
• Takeda
• Johnson & Johnson
• AstraZeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Novartis
• BIOTON
• Salix Pharmaceuticals
• AstraZeneca

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Rapid Acting
• Long Acting
• Short Acting
• Others

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetics in each application, can be divided into

• Hospital
• Clinic

Contents

United States Antidiabetics Market Report 2017

1 ANTIDIABETICS OVERVIEW

1.1 Product Overview and Scope of Antidiabetics
1.2 Classification of Antidiabetics
  1.2.1 Rapid Acting
  1.2.2 Long Acting
  1.2.3 Short Acting
  1.2.4 Others
1.3 Application of Antidiabetics
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antidiabetics (2011-2021)
  1.4.1 United States Antidiabetics Sales and Growth Rate (2011-2021)
  1.4.2 United States Antidiabetics Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIDIABETICS COMPETITION BY MANUFACTURERS

2.1 United States Antidiabetics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antidiabetics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antidiabetics Average Price by Manufactures (2015 and 2016)
2.4 Antidiabetics Market Competitive Situation and Trends
  2.4.1 Antidiabetics Market Concentration Rate
  2.4.2 Antidiabetics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIDIABETICS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Antidiabetics Sales and Market Share by States (2011-2016)
3.2 United States Antidiabetics Revenue and Market Share by States (2011-2016)
3.3 United States Antidiabetics Price by States (2011-2016)

4 UNITED STATES ANTIDIABETICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Antidiabetics Sales and Market Share by Type (2011-2016)
4.2 United States Antidiabetics Revenue and Market Share by Type (2011-2016)
4.3 United States Antidiabetics Price by Type (2011-2016)
4.4 United States Antidiabetics Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ANTIDIABETICS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Antidiabetics Sales and Market Share by Application (2011-2016)
5.2 United States Antidiabetics Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDIABETICS MANUFACTURERS PROFILES/ANALYSIS

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetics Product Type, Application and Specification
    6.1.2.1 Rapid Acting
    6.1.2.2 Long Acting
  6.1.3 Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Antidiabetics Product Type, Application and Specification
    6.2.2.1 Rapid Acting
    6.2.2.2 Long Acting
  6.2.3 Sanofi Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.2 Antidiabetics Product Type, Application and Specification
    6.3.2.1 Rapid Acting
    6.3.2.2 Long Acting
  6.3.3 Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.2 Antidiabetics Product Type, Application and Specification
    6.4.2.1 Rapid Acting
    6.4.2.2 Long Acting
  6.4.3 GlaxoSmithKline Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Antidiabetics Product Type, Application and Specification
    6.5.2.1 Rapid Acting
    6.5.2.2 Long Acting
  6.5.3 Merck Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 MannKind
  6.6.2 Antidiabetics Product Type, Application and Specification
    6.6.2.1 Rapid Acting
    6.6.2.2 Long Acting
  6.6.3 MannKind Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Takeda
  6.7.2 Antidiabetics Product Type, Application and Specification
    6.7.2.1 Rapid Acting
    6.7.2.2 Long Acting
  6.7.3 Takeda Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
  6.8.2 Antidiabetics Product Type, Application and Specification
    6.8.2.1 Rapid Acting
    6.8.2.2 Long Acting
  6.8.3 Johnson & Johnson Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.2 Antidiabetics Product Type, Application and Specification
    6.9.2.1 Rapid Acting
    6.9.2.2 Long Acting
  6.9.3 AstraZeneca Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb
  6.10.2 Antidiabetics Product Type, Application and Specification
    6.10.2.1 Rapid Acting
    6.10.2.2 Long Acting
  6.10.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim
6.12 Novartis
6.13 BIOTON
6.14 Salix Pharmaceuticals
6.15 AstraZeneca

7 ANTIDIABETICS MANUFACTURING COST ANALYSIS

7.1 Antidiabetics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidiabetics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDIABETICS MARKET FORECAST (2016-2021)

11.1 United States Antidiabetics Sales, Revenue Forecast (2016-2021)
11.2 United States Antidiabetics Sales Forecast by Type (2016-2021)
11.3 United States Antidiabetics Sales Forecast by Application (2016-2021)
11.4 Antidiabetics Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetics
Table Classification of Antidiabetics
Figure United States Sales Market Share of Antidiabetics by Type in 2015
Figure Rapid Acting Picture
Figure Long Acting Picture
Figure Short Acting Picture
Figure Others Picture
Table Application of Antidiabetics
Figure United States Sales Market Share of Antidiabetics by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Antidiabetics Sales and Growth Rate (2011-2021)
Figure United States Antidiabetics Revenue and Growth Rate (2011-2021)
Table United States Antidiabetics Sales of Key Manufacturers (2015 and 2016)
Table United States Antidiabetics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetics Sales Share by Manufacturers
Figure 2016 Antidiabetics Sales Share by Manufacturers
Table United States Antidiabetics Revenue by Manufacturers (2015 and 2016)
Table United States Antidiabetics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antidiabetics Revenue Share by Manufacturers
Table 2016 United States Antidiabetics Revenue Share by Manufacturers
Table United States Market Antidiabetics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antidiabetics Average Price of Key Manufacturers in 2015
Figure Antidiabetics Market Share of Top 3 Manufacturers
Figure Antidiabetics Market Share of Top 5 Manufacturers
Table United States Antidiabetics Sales by States (2011-2016)
Table United States Antidiabetics Sales Share by States (2011-2016)
Figure United States Antidiabetics Sales Market Share by States in 2015
Table United States Antidiabetics Revenue and Market Share by States (2011-2016)
Table United States Antidiabetics Revenue Share by States (2011-2016)
Figure Revenue Market Share of Antidiabetics by States (2011-2016)
Table United States Antidiabetics Price by States (2011-2016)
Table United States Antidiabetics Sales by Type (2011-2016)
Table United States Antidiabetics Sales Share by Type (2011-2016)
Figure United States Antidiabetics Sales Market Share by Type in 2015
Table United States Antidiabetics Revenue and Market Share by Type (2011-2016)
Table United States Antidiabetics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antidiabetics by Type (2011-2016)
Table United States Antidiabetics Price by Type (2011-2016)
Figure United States Antidiabetics Sales Growth Rate by Type (2011-2016)
Table United States Antidiabetics Sales by Application (2011-2016)
Table United States Antidiabetics Sales Market Share by Application (2011-2016)
Figure United States Antidiabetics Sales Market Share by Application in 2015
Table United States Antidiabetics Sales Growth Rate by Application (2011-2016)
Figure United States Antidiabetics Sales Growth Rate by Application (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Antidiabetics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Antidiabetics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Antidiabetics Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Antidiabetics Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Antidiabetics Sales Market Share (2011-2016)
Table MannKind Basic Information List
Table MannKind Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table MannKind Antidiabetics Sales Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Antidiabetics Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Antidiabetics Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antidiabetics Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Antidiabetics Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Novartis Basic Information List
Table BIOTON Basic Information List
Table Salix Pharmaceuticals Basic Information List
Table AstraZeneca Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetics
Figure Manufacturing Process Analysis of Antidiabetics
Figure Antidiabetics Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
Table Major Buyers of Antidiabetics
Table Distributors/Traders List
Figure United States Antidiabetics Production and Growth Rate Forecast (2016-2021)
Figure United States Antidiabetics Revenue and Growth Rate Forecast (2016-2021)
Table United States Antidiabetics Production Forecast by Type (2016-2021)
Table United States Antidiabetics Consumption Forecast by Application (2016-2021)
Table United States Antidiabetics Sales Forecast by States (2016-2021)
Table United States Antidiabetics Sales Share Forecast by States (2016-2021)